FLT4 and head and neck squamous cell carcinoma: In conclusion, VEGF-C/VEGFR3 mRNA expression at relapse may be of potential value as a new biomarker predicting nodal/soft tissue regional relapse and poor outcome after recurrence in HNSCC patients.